Observational Study
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. Sep 15, 2023; 15(9): 1662-1672
Published online Sep 15, 2023. doi: 10.4251/wjgo.v15.i9.1662
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Kaplan-Meier survival curves for hepatocellular carcinoma patients with different baseline fibrinogen-to-albumin ratio levels. FAR: Fibrinogen-to-albumin ratio.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Dose-response association between baseline fibrinogen-to-albumin ratio and the overall survival of hepatocellular carcinoma by using the quartiles.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Dose-response relationship between quantitative baseline fibrinogen-to-albumin ratio and the overall survival of hepatocellular carcinoma patients by using the restricted cubic spline. FAR: Fibrinogen-to-albumin ratio; HR: Hazard ratio.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Subgroup analysis stratified by aspartate aminotransferase, carbohydrate antigen 125 and clinical stage. 95%CI: 95% confidence interval; AST: Aspartate aminotransferase; CA125: Carbohydrate antigen 125; HR: Hazard ratio.